Treatment of SOD1-G93A mice with drugs selectively inhibiting iNOS delayed disease onset and extended survival in SOD1-G93A mice, further supporting the role of SC-driven inflammation in ALS pathology [212]. Here, SOD1 is linked to amyotrophic lateral sclerosis.